Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
23S ribosomal RNA is a large, catalytic RNA molecule (~2900 nucleotides in *E. coli*) that forms the core structural and enzymatic component of the 50S large subunit of prokaryotic ribosomes[7][2]. The 23S rRNA is divided into six major structural domains, with domain V harboring the peptidyl transferase center, the main catalytic site for peptide bond formation during protein synthesis[7][2]. This makes 23S rRNA essential for the fundamental process of translation in all bacteria and archaea, and it is the direct target of several classes of antibiotics that inhibit bacterial growth by binding to the peptidyl transferase center or nearby sites[2][7]. Resistance to these antibiotics is often linked to mutations or post-transcriptional modifications within the 23S rRNA sequence. In prokaryotes, 23S rRNA is accompanied by the 5S rRNA and approximately 31 ribosomal proteins to form the full 50S subunit, which associates with the 30S subunit to create the functional 70S ribosome[2][8]. 23S rRNA is not only structurally critical but also functions as a ribozyme, catalyzing the formation of peptide bonds—making it central to life and a validated and clinically exploited antimicrobial target[7][2].
Inhibition of peptide bond formation (peptidyl transferase activity); Interference with ribosomal function to block bacterial protein synthesis; Prevention of tRNA binding or translocation.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 23S ribosomal RNA of 50S ribosomal subunit (23S rRNA).